Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

3 ETFs to Buy if You Think Pfizer Will Beat Earnings

Pfizer (PFE) will showcase third-quarter results on Nov. 1, but investors will be more focused on the potential for its Inflectra drug, as well as its outlook on M&A.

The New York-based pharmaceutical giant recently announced it would launch its Inflectra drug in the U.S. nearly two years earlier than expected, which BMO Capital Markets analyst Alex Arfaei called "incrementally positive." The drug, which is a biosimilar to Janssen Biotech's Remicade, can be used for Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis...